https://www.myhealthnewsnevada.com/article/909983104-northeast-ohio-medical-university-neomed-celebrates-306-new-graduates-at-commencement-ceremony My Health News Nevada en PressRelease 2026-05-02T22:07:03+00:00 Northeast Ohio Medical University (NEOMED) Celebrates 306 New Graduates at Commencement Ceremony https://ml.globenewswire.com/media/MDgwNDNmM2ItZGZiNi00NTRjLTgzZTUtMDg3MjZjNjY0NGIyLTUwMDE1MDkxOS0yMDI2LTA1LTAyLWVu/tiny/Northeast-Ohio-Medical-Univers.png https://www.myhealthnewsnevada.com/article/909978301-memopryl-gets-reviewed-complete-formula-evaluation-of-ingredient-claims-and-side-effects-risk My Health News Nevada en PressRelease 2026-05-02T21:25:47+00:00 MemoPryl Gets Reviewed: Complete Formula Evaluation of Ingredient Claims and Side Effects Risk https://zingfast.com/wp-content/uploads/2026/05/MemoPryl-Reviews.jpg https://www.myhealthnewsnevada.com/article/909972974-visiocore-claims-evaluated-the-8-second-amazonian-morning-flush-for-crystal-clear-vision-support My Health News Nevada en PressRelease 2026-05-02T20:50:28+00:00 VisioCore Claims Evaluated: The 8-Second Amazonian Morning Flush For Crystal Clear Vision Support https://zingfast.com/wp-content/uploads/2026/05/VisioCore-Supplement.jpg https://www.myhealthnewsnevada.com/article/909966566-halo-care-skin-tag-remover-claims-evaluated-the-strongest-most-effective-mole-skin-tag-corrector-serum My Health News Nevada en PressRelease 2026-05-02T20:14:38+00:00 Halo Care Skin Tag Remover Claims Evaluated: The Strongest, Most Effective Mole & Skin Tag Corrector Serum https://zingfast.com/wp-content/uploads/2026/05/Halo-Care-Skin-Tag-Remover.jpg https://www.myhealthnewsnevada.com/article/909933274-milken-institute-global-conference-2026-set-to-open-tomorrow-in-beverly-hills-with-kfsh-participation My Health News Nevada en PressRelease 2026-05-02T16:00:00+00:00 Milken Institute Global Conference 2026 Set to Open Tomorrow in Beverly Hills with KFSH Participation https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://www.myhealthnewsnevada.com/article/909933276-la-milken-institute-global-conference-2026-se-inaugura-ma-ana-en-beverly-hills-con-la-participaci-n-de-kfsh My Health News Nevada en PressRelease 2026-05-02T16:00:00+00:00 La Milken Institute Global Conference 2026 se inaugura mañana en Beverly Hills con la participación de KFSH https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://www.myhealthnewsnevada.com/article/909933282-tem-in-cio-amanh-em-beverly-hills-a-milken-institute-global-conference-2026-com-a-participa-o-do-kfsh My Health News Nevada en PressRelease 2026-05-02T16:00:00+00:00 Tem Início Amanhã em Beverly Hills a Milken Institute Global Conference 2026 com a Participação do KFSH https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://www.myhealthnewsnevada.com/article/909797332-avicanna-announces-change-in-board-of-directors My Health News Nevada en PressRelease 2026-05-02T00:46:30+00:00 Avicanna Announces Change in Board of Directors https://ml.globenewswire.com/media/c9abc2f4-efdc-40f6-921d-a5da048eda46/small/avicanna-logo-colour-withtm-01-png.png https://www.myhealthnewsnevada.com/article/909766133-pennant-acquires-senior-living-communities-in-arizona-and-wisconsin My Health News Nevada en PressRelease 2026-05-01T22:28:47+00:00 Pennant Acquires Senior Living Communities in Arizona and Wisconsin https://ml.globenewswire.com/media/d50f543c-fc54-437d-8007-600644587dfe/small/pennant-logo-png.png https://www.myhealthnewsnevada.com/article/909766101-qu-ocurre-despu-s-del-avance-en-kfsh-la-innovaci-n-se-mide-por-la-repetici-n My Health News Nevada en PressRelease 2026-05-01T22:06:55+00:00 Qué ocurre después del avance: En KFSH, la innovación se mide por la repetición https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://www.myhealthnewsnevada.com/article/909766148-o-que-acontece-depois-do-grande-avan-o-no-kfsh-a-inova-o-medida-pela-repeti-o My Health News Nevada en PressRelease 2026-05-01T22:06:55+00:00 O Que Acontece Depois do Grande Avanço: No KFSH, a Inovação é Medida pela Repetição https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://www.myhealthnewsnevada.com/article/909752737-zentalis-pharmaceuticals-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4 My Health News Nevada en PressRelease 2026-05-01T21:30:00+00:00 Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/1b481d6d-51c9-44f0-b33f-81feb1061d2e/small/zentalis-logo-png.png https://www.myhealthnewsnevada.com/article/909752702-eupraxia-pharmaceuticals-appoints-dr-jeymi-tambiah-as-chief-medical-officer My Health News Nevada en PressRelease 2026-05-01T21:05:06+00:00 Eupraxia Pharmaceuticals Appoints Dr. Jeymi Tambiah as Chief Medical Officer https://ml.globenewswire.com/media/0b2bbe4b-1cf9-402e-8ea6-22c0043f310a/small/eupraxia-color-med-res-01-jpg.jpg https://www.myhealthnewsnevada.com/article/909752698-celcuity-s-phase-3-viktoria-1-trial-achieves-primary-endpoint-with-clinically-meaningful-improvement-in-progression-free-survival-in-pik3ca-mutant My Health News Nevada en PressRelease 2026-05-01T21:03:22+00:00 Celcuity's Phase 3 VIKTORIA-1 Trial Achieves Primary Endpoint With Clinically Meaningful Improvement in Progression-Free Survival in PIK3CA Mutant Cohort https://ml.globenewswire.com/media/dab74495-313f-47dd-a6cb-b42a7f024edd/small/celcuity-logo-rgb-jpg.jpg https://www.myhealthnewsnevada.com/article/909746112-newamsterdam-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 My Health News Nevada en PressRelease 2026-05-01T20:57:13+00:00 NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/f7b8b881-9461-4712-9965-707ed3bdd573/small/newamsterdam-logo-full-color-final-png.png https://www.myhealthnewsnevada.com/article/909746100-refills-glp-1-weight-loss-claims-evaluated-the-most-affordable-personalized-semaglutide-tirzepatide-glp1-program-with-online-doctor-support My Health News Nevada en PressRelease 2026-05-01T20:54:10+00:00 Refills GLP-1 Weight Loss Claims Evaluated: The Most Affordable Personalized Semaglutide & Tirzepatide GLP1 Program with Online Doctor Support https://zingfast.com/wp-content/uploads/2026/05/Refills-GLP-1-Weight-Loss.jpg https://www.myhealthnewsnevada.com/article/909746056-equillium-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 My Health News Nevada en PressRelease 2026-05-01T20:42:32+00:00 Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/14ce766d-e697-461f-a27c-c1ee49c0eeff/small/equillium-logo-360x180-jpg.jpg https://www.myhealthnewsnevada.com/article/909738830-oric-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 My Health News Nevada en PressRelease 2026-05-01T20:30:00+00:00 ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/acbc0ad2-7a44-4ee7-b729-ab92d57ffafb/small/oric-png.png https://www.myhealthnewsnevada.com/article/909738963-celularity-announces-filing-of-form-10-k-regains-nasdaq-compliance-and-highlights-continued-strategic-transformation My Health News Nevada en PressRelease 2026-05-01T20:30:00+00:00 Celularity Announces Filing of Form 10-K, Regains Nasdaq Compliance and Highlights Continued Strategic Transformation https://ml.globenewswire.com/media/NjdlZDZmZTAtM2Q4ZS00MWYzLWJhMzQtODEzMDk1YjI0OWNlLTEyMTY1NjItMjAyNi0wNS0wMS1lbg==/tiny/Celularity-Inc-.png https://www.myhealthnewsnevada.com/article/909739278-dianthus-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 My Health News Nevada en PressRelease 2026-05-01T20:30:00+00:00 Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/c9002285-2240-4dab-aced-77296f86a3fa/small/dianthus-logo-primary-full-color-cmyk-png.png https://www.myhealthnewsnevada.com/article/909739339-spyre-therapeutics-announces-grants-of-inducement-awards My Health News Nevada en PressRelease 2026-05-01T20:28:07+00:00 Spyre Therapeutics Announces Grants of Inducement Awards https://ml.globenewswire.com/media/bc26a912-b583-43c6-8423-55a4ba2bf4bd/small/spyre-logo-horizontal-full-color-rgb-583px-300ppi-jpg.jpg https://www.myhealthnewsnevada.com/article/909738773-inspiremd-announces-fda-approval-of-investigational-device-exemption-application-for-cguardians-iii-pivotal-study-of-the-switchguard-neuro-protection My Health News Nevada en PressRelease 2026-05-01T20:05:00+00:00 InspireMD Announces FDA Approval of Investigational Device Exemption Application for CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System https://ml-eu.globenewswire.com/media/5aefda10-5578-41c7-a1c0-9c4b700687c0/small/inspiremd-jpg.jpg https://www.myhealthnewsnevada.com/article/909738775-inspiremd-initiates-voluntary-u-s-recall-of-cguard-prime-135-cm-carotid-stent-delivery-system My Health News Nevada en PressRelease 2026-05-01T20:05:00+00:00 InspireMD Initiates Voluntary U.S. Recall of CGuard® Prime 135 cm Carotid Stent Delivery System https://ml-eu.globenewswire.com/media/5aefda10-5578-41c7-a1c0-9c4b700687c0/small/inspiremd-jpg.jpg https://www.myhealthnewsnevada.com/article/909738791-taysha-gene-therapies-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4 My Health News Nevada en PressRelease 2026-05-01T20:05:00+00:00 Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/a88cd5f5-0b05-416c-a56b-e4130c10cfca/small/new-taysha-inline-fullcolor-rgb-12in-300ppi-jpg.jpg https://www.myhealthnewsnevada.com/article/909738836-solid-biosciences-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 My Health News Nevada en PressRelease 2026-05-01T20:05:00+00:00 Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/bb5e6b30-d9d9-464f-8c64-33a09eacc3fb/small/solid-1029x579-png.png https://www.myhealthnewsnevada.com/article/909738914-candel-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 My Health News Nevada en PressRelease 2026-05-01T20:05:00+00:00 Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/8b82e1e3-4a67-4472-a7c8-05f9d24c9bb0/small/candel-logo-fullcolor-4-png.png https://www.myhealthnewsnevada.com/article/909739139-fate-therapeutics-reports-new-employee-inducement-award-under-nasdaq-listing-rule-5635-c-4 My Health News Nevada en PressRelease 2026-05-01T20:05:00+00:00 Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/2acb7cd9-5f5c-42d0-a606-72d085e2fe6e/small/fate-therapeutics-jpg.jpg https://www.myhealthnewsnevada.com/article/909732246-xenon-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 My Health News Nevada en PressRelease 2026-05-01T20:01:00+00:00 Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/505b89d3-dfd1-46e8-bc3b-3c9c699ef7ec/small/xenon-logo-tm-full-color-250x80px-png.png https://www.myhealthnewsnevada.com/article/909732252-intellia-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 My Health News Nevada en PressRelease 2026-05-01T20:01:00+00:00 Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/9b6b17bb-c8a4-4009-b5f8-8cadb4d2296a/small/intellia-jpg.jpg https://www.myhealthnewsnevada.com/article/909732282-avalyn-announces-closing-of-initial-public-offering-and-full-exercise-of-underwriters-option-to-purchase-additional-shares My Health News Nevada en PressRelease 2026-05-01T20:01:00+00:00 Avalyn Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares https://ml.globenewswire.com/media/84d7bff4-ce17-433b-8c71-aa20c30f9f43/small/avalyn-logo-final-png.png https://www.myhealthnewsnevada.com/article/909732349-tstrive-review-a-new-balanced-look-at-the-men-s-vitality-and-energy-supplement My Health News Nevada en PressRelease 2026-05-01T20:00:44+00:00 Tstrive Review: A New Balanced Look at the Men’s Vitality and Energy Supplement https://ml.globenewswire.com/media/8d72a214-ab22-406c-8b1b-348acd2d4a85/small/555-jpg.jpg https://www.myhealthnewsnevada.com/article/909732300-derma-essential-claims-evaluated-investigating-the-ingredients-inside-dermaessential-healthy-skin-support-formula My Health News Nevada en PressRelease 2026-05-01T19:47:17+00:00 Derma Essential Claims Evaluated: Investigating the Ingredients Inside DermaEssential Healthy Skin Support Formula https://zingfast.com/wp-content/uploads/2026/05/Derma-Essential.jpg https://www.myhealthnewsnevada.com/article/909725422-gala-glp-1-weight-loss-claims-evaluated-the-most-trusted-glp1-tirzepetide-telehealth-prescription-treatment-tracker-provider My Health News Nevada en PressRelease 2026-05-01T19:17:18+00:00 Gala GLP-1 Weight Loss Claims Evaluated: The Most Trusted GLP1 Tirzepetide Telehealth Prescription Treatment & Tracker Provider https://zingfast.com/wp-content/uploads/2026/05/Gala-GLP-1-Weight-Loss.jpg https://www.myhealthnewsnevada.com/article/909718727-what-happens-after-the-breakthrough-at-kfsh-innovation-is-measured-by-repetition My Health News Nevada en PressRelease 2026-05-01T18:40:00+00:00 What Happens After the Breakthrough: At KFSH, Innovation Is Measured by Repetition https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://www.myhealthnewsnevada.com/article/909698748-human-garage-launches-global-28-day-reset-on-may-1-to-help-millions-release-stress-and-pain My Health News Nevada en PressRelease 2026-05-01T17:26:46+00:00 Human Garage launches Global 28-Day Reset on May 1 to help millions release stress and pain https://ml.globenewswire.com/media/8955d53b-9b2b-4fa6-ade8-e86efec4b87b/small/unnamed-jpg.jpg https://www.myhealthnewsnevada.com/article/909687364-arvinas-announces-fda-approval-of-veppanu-vepdegestrant-for-the-treatment-of-esr1m-er-her2-advanced-breast-cancer My Health News Nevada en PressRelease 2026-05-01T16:43:18+00:00 Arvinas Announces FDA Approval of VEPPANU (vepdegestrant) for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer https://ml.globenewswire.com/media/563780a0-f8d9-4e37-8665-b622ef2caa5b/small/arvinas-logoart-lg-jpg.jpg https://www.myhealthnewsnevada.com/article/909687295-confluent-medical-technologies-names-tom-testa-as-chief-operating-officer My Health News Nevada en PressRelease 2026-05-01T16:30:18+00:00 Confluent Medical Technologies Names Tom Testa as Chief Operating Officer https://ml.globenewswire.com/media/e39458f8-b884-4738-b1f0-5dd6046a9d4e/medium/tom-testa-coo.JPG https://www.myhealthnewsnevada.com/article/909682353-rezolute-announces-oral-presentation-of-results-from-its-phase-3-sunrize-study-of-ersodetug-in-patients-with-congenital-hyperinsulinism-at-the My Health News Nevada en PressRelease 2026-05-01T16:15:00+00:00 Rezolute Announces Oral Presentation of Results From its Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism at the Pediatric Endocrine Society Annual Meeting https://ml.globenewswire.com/media/d26d1af6-0969-4bba-b973-6d2294367aae/medium/figure-1.PNG https://www.myhealthnewsnevada.com/article/909671323-hyperion-defi-schedules-first-quarter-earnings-call-for-thursday-may-14-at-8-00-a-m-et My Health News Nevada en PressRelease 2026-05-01T15:12:40+00:00 Hyperion DeFi Schedules First Quarter Earnings Call for Thursday, May 14 at 8:00 a.m. ET https://ml.globenewswire.com/media/2b21f207-e46f-4ad9-a6be-573e0bdc6c4c/small/hyperion-defi-single-logo-jpg.jpg https://www.myhealthnewsnevada.com/article/909662716-reena-announces-1-9m-provincial-investment-and-lead-donations-for-thornhill-community-health-centre-a-reena-initiative My Health News Nevada en PressRelease 2026-05-01T14:39:34+00:00 Reena Announces $1.9M Provincial Investment and Lead Donations for Thornhill Community Health Centre – A Reena Initiative https://ml.globenewswire.com/media/ZWFlZGZlODYtOWM4Ni00ZTQ1LThhOWItYmU3YzI5YjUwYjYwLTUwMDE2MTk3Mi0yMDI2LTA1LTAxLWVu/tiny/Reena.png https://www.myhealthnewsnevada.com/article/909662699-membrane-and-filtration-market-to-reach-591-2-billion-by-2030-driven-by-climate-change-infrastructure-investments My Health News Nevada en PressRelease 2026-05-01T14:38:49+00:00 Membrane and Filtration Market to Reach $591.2 Billion by 2030, Driven by Climate Change Infrastructure Investments https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png https://www.myhealthnewsnevada.com/article/909662710-youth-reporting-frequent-thoughts-of-suicide-reached-record-high-in-2025-screening-data-show My Health News Nevada en PressRelease 2026-05-01T14:28:15+00:00 Youth reporting frequent thoughts of suicide reached record high in 2025, screening data show https://ml.globenewswire.com/media/Mjg0YzdhOGYtOTg0Zi00YjZmLTllNmEtNmEyYTdhMDk5ZGQ0LTEyMTM0MjktMjAyNi0wNS0wMS1lbg==/tiny/Mental-Health-America.png https://www.myhealthnewsnevada.com/article/909662657-safespace-global-corporation-opens-tennessee-ai-center-of-excellence-marking-defining-commercialization-milestone My Health News Nevada en PressRelease 2026-05-01T14:24:57+00:00 SafeSpace Global Corporation Opens Tennessee AI Center of Excellence, Marking Defining Commercialization Milestone https://ml.globenewswire.com/media/3badd21c-da2d-4553-9574-d7585480833c/medium/safespace-global-corporation.png https://www.myhealthnewsnevada.com/article/909657583-breaking-the-silence-on-women-s-urologic-health My Health News Nevada en PressRelease 2026-05-01T14:03:00+00:00 Breaking the Silence on Women’s Urologic Health https://ml.globenewswire.com/media/YTQzNzIyN2QtYzMxMS00MzE1LTlhZTQtYTkzOTVkMWYzYWY0LTEyNzU5NzctMjAyNi0wNS0wMS1lbg==/tiny/Urology-Care-Foundation.png https://www.myhealthnewsnevada.com/article/909657535-intercontinental-air-ambulance-transport-highlights-complexity-of-neurological-and-post-trauma-care My Health News Nevada en PressRelease 2026-05-01T14:00:00+00:00 Intercontinental Air Ambulance Transport Highlights Complexity of Neurological and Post-Trauma Care https://ml-eu.globenewswire.com/media/fb1f2756-58ec-41fe-91fe-2835a4ce3c0f/medium/international-patient-transport-bed-to-bed-service.png https://www.myhealthnewsnevada.com/article/909657626-sbc-medical-to-announce-1q-2026-financial-results My Health News Nevada en PressRelease 2026-05-01T14:00:00+00:00 SBC Medical to Announce 1Q 2026 Financial Results https://ml.globenewswire.com/media/MWJjMGE3MjYtZDRlMy00ODU4LTgxZmUtNzgyMTMxZDU2M2IyLTEzMDc5MDMtMjAyNi0wNS0wMS1lbg==/tiny/SBC-Medical-Group-Holdings-Inc.png https://www.myhealthnewsnevada.com/article/909648618-trinity-biotech-appoints-jerry-lydon-to-lead-north-america-commercial-operations My Health News Nevada en PressRelease 2026-05-01T13:27:00+00:00 Trinity Biotech Appoints Jerry Lydon to Lead North America Commercial Operations https://ml.globenewswire.com/media/23a9d0e4-6c22-4509-971e-0c09c45ec985/small/trinity-biotech-plc-logo.jpg https://www.myhealthnewsnevada.com/article/909648409-nasus-pharma-to-participate-in-upcoming-investor-conferences My Health News Nevada en PressRelease 2026-05-01T13:13:59+00:00 Nasus Pharma to Participate in Upcoming Investor Conferences https://ml-eu.globenewswire.com/media/635331e1-7b05-412a-b2db-eebfda31ae81/small/nasus-pharma-logo-png.png https://www.myhealthnewsnevada.com/article/909648543-senseonics-holdings-inc-schedules-first-quarter-2026-earnings-release-and-conference-call-for-may-7-2026-at-4-30-p-m-eastern-time My Health News Nevada en PressRelease 2026-05-01T13:10:31+00:00 Senseonics Holdings, Inc. Schedules First Quarter 2026 Earnings Release and Conference Call for May 7, 2026 at 4:30 P.M. Eastern Time https://ml.globenewswire.com/media/7f64f449-dd5d-4bd1-9504-82adb3846669/small/logo-png.png https://www.myhealthnewsnevada.com/article/909644275-the-zealand-pharma-board-of-directors-proposes-to-elect-camilla-sylvest-to-the-board-of-directors-at-an-upcoming-extraordinary-general-meeting My Health News Nevada en PressRelease 2026-05-01T13:01:00+00:00 The Zealand Pharma Board of Directors proposes to elect Camilla Sylvest to the Board of Directors at an upcoming Extraordinary General Meeting https://ml-eu.globenewswire.com/media/31b5d115-c4a3-4dfd-b20e-d222199c4862/small/zealand-logo-1-png.png https://www.myhealthnewsnevada.com/article/909644259-coloplast-receives-innovative-technology-contract-from-vizient-for-biatain-silicone-fit My Health News Nevada en PressRelease 2026-05-01T13:00:00+00:00 Coloplast Receives Innovative Technology Contract from Vizient for Biatain® Silicone Fit https://ml-eu.globenewswire.com/media/9de3c9b2-934d-44da-ab32-c5f9ba5d9bfe/small/coloplast-logo-jpg.JPG https://www.myhealthnewsnevada.com/article/909644271-zealand-pharma-convenes-extraordinary-general-meeting-on-may-26-2026 My Health News Nevada en PressRelease 2026-05-01T13:00:00+00:00 Zealand Pharma convenes Extraordinary General Meeting on May 26, 2026 https://ml-eu.globenewswire.com/media/31b5d115-c4a3-4dfd-b20e-d222199c4862/small/zealand-logo-1-png.png https://www.myhealthnewsnevada.com/article/909644561-work-medical-deepens-web3-0-strategic-layout-co-authors-asset-tokenization-whitepaper My Health News Nevada en PressRelease 2026-05-01T13:00:00+00:00 WORK Medical Deepens Web3.0 Strategic Layout: Co-authors Asset Tokenization Whitepaper https://ml.globenewswire.com/media/7c9dd1a3-c713-4b34-820d-2c5ef0c0e8b7/small/wok-logo-png.png https://www.myhealthnewsnevada.com/article/909644755-j-star-holding-partners-with-patriot-green-energy-technology-for-made-in-usa-solid-state-battery-solutions My Health News Nevada en PressRelease 2026-05-01T13:00:00+00:00 J-Star Holding Partners with Patriot Green Energy Technology for Made-In-USA Solid-State Battery Solutions https://ml.globenewswire.com/media/1a4c6faf-93be-4d28-a35f-1df9c4f0404e/small/j-star-logo-blue-transparent-png.png https://www.myhealthnewsnevada.com/article/909640770-specialty-nutrition-names-alejandra-gratson-managing-partner-strengthening-innovation-and-commercialization-leadership My Health News Nevada en PressRelease 2026-05-01T12:40:31+00:00 Specialty Nutrition Names Alejandra Gratson Managing Partner, Strengthening Innovation and Commercialization Leadership https://ml.globenewswire.com/media/c4c5708d-fadb-4769-aa94-611bf1f49a88/medium/alejandra-gratson-phd-joins-specialty-nutrition-as-managing.jpg https://www.myhealthnewsnevada.com/article/909640767-breaking-the-silence-bladder-cancer-awareness-month-begins My Health News Nevada en PressRelease 2026-05-01T12:32:37+00:00 Breaking the Silence: Bladder Cancer Awareness Month Begins https://ml.globenewswire.com/media/ZmMzYmE2NGItNWFkNC00ZjdjLWIyOWMtNjRlZmFlMmQ4NzNkLTUwMDE1NTc1NS0yMDI2LTA1LTAxLWVu/tiny/Bladder-Cancer-Advocacy-Networ.png https://www.myhealthnewsnevada.com/article/909640682-abeona-therapeutics-announces-new-employee-inducement-grants-under-nasdaq-listing-rule-5635-c-4 My Health News Nevada en PressRelease 2026-05-01T12:30:00+00:00 Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/f11f9f14-9744-4666-aef3-9771488c41bd/small/thumb-1740-12-silhouette-vertical-full-color-png.png https://www.myhealthnewsnevada.com/article/909640690-pelthos-therapeutics-to-report-first-quarter-2026-financial-results-on-may-14-2026 My Health News Nevada en PressRelease 2026-05-01T12:30:00+00:00 Pelthos Therapeutics to Report First Quarter 2026 Financial Results on May 14, 2026 https://ml.globenewswire.com/media/7d71f2d0-a48f-4fe0-a49c-138de21bc0e1/small/pelthos-logo-rgb-png.png https://www.myhealthnewsnevada.com/article/909640734-iradimed-corporation-reports-first-quarter-2026-financial-results My Health News Nevada en PressRelease 2026-05-01T12:30:00+00:00 IRADIMED CORPORATION Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/f353c867-559d-43a8-935c-ab497045e743/small/logo-gif.gif https://www.myhealthnewsnevada.com/article/909636025-inspira-secures-596-000-ame-system-order-from-leading-irish-technological-university My Health News Nevada en PressRelease 2026-05-01T12:21:00+00:00 Inspira Secures $596,000 AME System Order from Leading Irish Technological University https://ml.globenewswire.com/media/6a4eabfe-c9ec-40d1-87fc-6f0d8e6e408c/small/screenshot-2025-04-02-at-19-21-06-png.png https://www.myhealthnewsnevada.com/article/909636024-weight-watchers-expands-med-with-access-to-new-ozempic-pill-semaglutide My Health News Nevada en PressRelease 2026-05-01T12:05:00+00:00 Weight Watchers Expands Med+ With Access to New Ozempic® pill (semaglutide) https://ml.globenewswire.com/media/f435b439-7f75-4d2f-a6cc-0e4e2ed811ea/small/weightwatchers-wordmark-boldblue-png.png https://www.myhealthnewsnevada.com/article/909631740-invitria-showcases-exbumin-and-optibumin-25-at-ipec-excipient-world-biologics-summit-recombinant-human-serum-albumins-already-used-in-on-market My Health News Nevada en PressRelease 2026-05-01T12:00:00+00:00 InVitria Showcases Exbumin® and Optibumin® 25 at IPEC Excipient World: Biologics Summit: Recombinant Human Serum Albumins Already Used in On-Market Approved Biologics https://ml.globenewswire.com/media/a765699d-9866-4c97-be6f-7c3390501d12/small/invitria-logo-performance-defined-800-x-400-px-png.png https://www.myhealthnewsnevada.com/article/909631744-medaire-and-nbaa-partner-to-bring-peer-support-access-to-individual-aviation-professionals My Health News Nevada en PressRelease 2026-05-01T12:00:00+00:00 MedAire and NBAA Partner to Bring Peer Support Access to Individual Aviation Professionals https://ml.globenewswire.com/media/M2ZmM2FmMjUtMjViZi00Yzk0LWE0MTMtNDVjY2Y0NzgyMWNiLTEyMzYwOTUtMjAyNi0wNS0wMS1lbg==/tiny/MedAire.png https://www.myhealthnewsnevada.com/article/909631755-stryker-to-participate-in-the-bank-of-america-securities-2026-global-healthcare-conference My Health News Nevada en PressRelease 2026-05-01T12:00:00+00:00 Stryker to participate in the Bank of America Securities 2026 Global Healthcare Conference https://ml.globenewswire.com/media/c24fe8bd-9db6-4f42-8a52-06a4e1b673b5/small/stryker-logo2015-jpg.jpg https://www.myhealthnewsnevada.com/article/909631788-damora-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 My Health News Nevada en PressRelease 2026-05-01T12:00:00+00:00 Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/547722cf-495b-4464-97a9-35bea3fa5d15/small/damora-rgb-png.png https://www.myhealthnewsnevada.com/article/909631814-health-catalyst-to-announce-first-quarter-2026-operating-results-and-host-conference-call-on-monday-may-11-2026 My Health News Nevada en PressRelease 2026-05-01T12:00:00+00:00 Health Catalyst to Announce First Quarter 2026 Operating Results and Host Conference Call on Monday, May 11, 2026 https://ml.globenewswire.com/media/95973775-03d2-4696-b65c-c43ff730af3a/small/picture1-jpg.jpg https://www.myhealthnewsnevada.com/article/909631824-phathom-pharmaceuticals-to-highlight-voquezna-vonoprazan-at-ddw-2026-annual-meeting My Health News Nevada en PressRelease 2026-05-01T12:00:00+00:00 Phathom Pharmaceuticals to Highlight VOQUEZNA® (vonoprazan) at DDW 2026 Annual Meeting https://ml.globenewswire.com/media/0baa6f51-c6cb-4b21-a4e0-573a18b8171c/small/phathom-pharm-logo-jpg.jpg https://www.myhealthnewsnevada.com/article/909631880-vaxart-to-host-stockholder-fireside-chat-on-may-8-at-4-30-p-m-et My Health News Nevada en PressRelease 2026-05-01T12:00:00+00:00 Vaxart to Host Stockholder Fireside Chat on May 8 at 4:30 p.m. ET https://ml.globenewswire.com/media/aedaf06c-26f8-482c-ac72-39774eab2c35/small/vxrt-logo-jpg.png https://www.myhealthnewsnevada.com/article/909631906-nova-leap-health-corp-announces-closing-of-strategic-acquisition-in-nova-scotia My Health News Nevada en PressRelease 2026-05-01T11:55:00+00:00 Nova Leap Health Corp. announces Closing of Strategic Acquisition in Nova Scotia https://ml.globenewswire.com/media/fbaf04b7-e5a6-4cf8-9f59-52ece837a3e0/small/e-mail-logo-picture-jpg.jpg https://www.myhealthnewsnevada.com/article/909628098-inflarx-to-report-first-quarter-2026-results-on-may-7-2026 My Health News Nevada en PressRelease 2026-05-01T11:30:00+00:00 InflaRx to Report First Quarter 2026 Results on May 7, 2026 https://ml.globenewswire.com/media/e017df5c-9a9b-4f4f-9a94-6c2eeb0400bc/small/inflarx-logo-png.png https://www.myhealthnewsnevada.com/article/909624270-axsome-therapeutics-hosts-auvelity-fda-approval-investor-event-featuring-expert-thought-leader My Health News Nevada en PressRelease 2026-05-01T11:15:00+00:00 Axsome Therapeutics Hosts AUVELITY® FDA Approval Investor Event Featuring Expert Thought Leader https://ml.globenewswire.com/media/1186f248-bfb6-4258-a391-f2ffd94c5d76/small/axsome-r-morpheus-logo-pos-rgb-png.png https://www.myhealthnewsnevada.com/article/909624167-noema-pharma-to-present-phase-2a-results-for-cendifensine-in-vasomotor-symptoms-hot-flashes-due-to-menopause-at-the-2026-acog-annual-clinical My Health News Nevada en PressRelease 2026-05-01T11:00:00+00:00 Noema Pharma to Present Phase 2a Results for Cendifensine in Vasomotor Symptoms (Hot Flashes) Due to Menopause at the 2026 ACOG Annual Clinical & Scientific Meeting https://ml.globenewswire.com/media/7fa49030-145d-4bf4-8fa1-3bdd6900fc5c/small/noema-logo-lockup-color-on-transparent-rgb-1-png.png https://www.myhealthnewsnevada.com/article/909624234-molecular-partners-publishes-phase-1-mp0317-data-in-nature-cancer-demonstrating-tumor-localized-cd40-activation-and-tumor-microenvironment-remodeling My Health News Nevada en PressRelease 2026-05-01T11:00:00+00:00 Molecular Partners publishes Phase 1 MP0317 data in Nature Cancer demonstrating tumor-localized CD40 activation and tumor microenvironment remodeling https://ml.globenewswire.com/media/ac0d728a-e43a-4d2b-a9c5-52e74d0dd1eb/small/molecularpartners-logo-jpg.jpg https://www.myhealthnewsnevada.com/article/909624272-maplight-therapeutics-announces-completion-of-enrollment-in-zephyr-phase-2-trial-and-updates-expected-timing-of-topline-results My Health News Nevada en PressRelease 2026-05-01T11:00:00+00:00 MapLight Therapeutics Announces Completion of Enrollment in ZEPHYR Phase 2 Trial and Updates Expected Timing of Topline Results https://ml.globenewswire.com/media/173b471e-5a67-4f12-84f2-06f4980ebd76/small/maplight-logo-horizontal-web-color-png.png https://www.myhealthnewsnevada.com/article/909620190-pluristyx-and-qkine-announce-a-reciprocal-distribution-agreement-in-support-of-optimized-growth-factor-differentiation-of-induced-pluripotent-stem My Health News Nevada en PressRelease 2026-05-01T10:57:00+00:00 Pluristyx and Qkine Announce a Reciprocal Distribution Agreement in Support of Optimized Growth Factor Differentiation of Induced Pluripotent Stem Cell (iPSC) https://ml.globenewswire.com/media/bcb451b5-83a5-421f-9fb7-ae3b5c72fc0b/medium/qkine-plsx.png https://www.myhealthnewsnevada.com/article/909620212-rhythm-pharmaceuticals-announces-imcivree-setmelanotide-granted-marketing-authorization-by-european-commission-for-the-treatment-of-obesity-and My Health News Nevada en PressRelease 2026-05-01T10:55:00+00:00 Rhythm Pharmaceuticals Announces IMCIVREE® (Setmelanotide) Granted Marketing Authorization by European Commission for the Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity https://ml.globenewswire.com/media/b767aaa5-9915-465f-9233-d97757f4e387/small/rhythm-logo-rgb-jpg-registration-mark-jpg.jpg https://www.myhealthnewsnevada.com/article/909620197-eton-pharmaceuticals-relaunches-hemangeol-propranolol-oral-solution-with-eton-cares-and-exclusive-specialty-pharmacy-distribution My Health News Nevada en PressRelease 2026-05-01T10:50:00+00:00 Eton Pharmaceuticals relaunches HEMANGEOL® (propranolol) Oral Solution with Eton Cares and Exclusive Specialty Pharmacy Distribution https://ml.globenewswire.com/media/db07cafa-b35c-4d61-a1a1-d330caf67ad2/small/eton-logo-png.png https://www.myhealthnewsnevada.com/article/909612665-brightspring-health-services-inc-reports-first-quarter-2026-financial-results-and-increases-full-year-2026-guidance My Health News Nevada en PressRelease 2026-05-01T10:00:00+00:00 BrightSpring Health Services, Inc. Reports First Quarter 2026 Financial Results and Increases Full Year 2026 Guidance https://ml.globenewswire.com/media/db25f94c-83a2-46ba-8d53-c9a0768a71bd/small/brightspring-healthservices-jpg.jpg https://www.myhealthnewsnevada.com/article/909592058-oculis-to-present-at-upcoming-association-for-research-in-vision-and-ophthalmology-arvo-annual-meeting My Health News Nevada en PressRelease 2026-05-01T08:00:00+00:00 Oculis to Present at Upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting https://ml-eu.globenewswire.com/media/f6fa6e90-83a4-4baa-a3b6-5483017d26b9/small/oculis-logo-gradient-jpg-resized-jpg.jpg https://www.myhealthnewsnevada.com/article/909576849-nxera-pharma-operational-highlights-and-consolidated-results-for-the-first-quarter-2026 My Health News Nevada en PressRelease 2026-05-01T06:36:34+00:00 Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2026 https://ml-eu.globenewswire.com/media/5cc74d52-c86f-4e21-8684-3496281fee15/small/nxera-master-logo-rgb-black-1-png.png https://www.myhealthnewsnevada.com/article/909531120-memopryl-under-investigation-2026-official-website-scam-warning-update-avoid-fake-complaints-hidden-risks My Health News Nevada en PressRelease 2026-05-01T02:20:12+00:00 MemoPryl Under Investigation (2026 Official Website Scam WARNING Update) Avoid Fake Complaints & Hidden Risks https://zingfast.com/wp-content/uploads/2026/05/MemoPryl-Reviews-Scam-Warning.jpg https://www.myhealthnewsnevada.com/article/909524504-senseonics-announces-pricing-of-80-million-public-offering-of-common-stock-and-pre-funded-warrants My Health News Nevada en PressRelease 2026-05-01T01:50:21+00:00 Senseonics Announces Pricing of $80 Million Public Offering of Common Stock and Pre-Funded Warrants https://ml.globenewswire.com/media/7f64f449-dd5d-4bd1-9504-82adb3846669/small/logo-png.png